Stockreport

Arbutus receives clearance to initiate early-stage AB-729 trial; shares up 8% premarket [Seeking Alpha]

Arbutus Biopharma Corporation  (ABUS) 
Last arbutus biopharma corporation earnings: 11/6 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.arbutusbio.com/node/5806
PDF Arbutus receives clearance to initiate early-stage AB-729 trial; shares up 8% premarket - Arbutus Biopharma Corporation (NASDAQ:ABUS) | Seeking Alpha Healthcare | On the [Read more]